Your Article Summary
See Latest Articles(Click the title below to leave the MDLinx Network and go to the Journal's Website)
Avigen Reports Third Quarter 2008 Financial Results
Avigen, 01/09/09
Avigen, Inc., a biopharmaceutical company innovating therapeutics for neurological care, reported financial results. Avigen had approximately $56 million in financial assets, including cash, cash equivalents, and available-for-sale securities and restricted investments, compared with approximately $78 million at December 31, 2007.
Today in Financial Reports...keeping you current
Receive free subspecialty "5-minute updates" via email
HP to Acquire Networking Firm 3Com
HealthDataManagement, 11/20/09
Protox Reports 2009 Third Quarter Results
Protox Therapeutics , 11/18/09
King Pharmaceuticals to Present at Lazard Capital Markets Healthcare Conference
King Pharmaceuticals, 11/16/09